Analia Azaro, Global Development Medical Director, Hematology Oncology at AstraZeneca, shared on LinkedIn:
“I am pleasant o share that I have stepped into a new role at AstraZeneca as Global Development Medical Director, Hematology Oncology.
After my experience as Medical Director in Early Oncology R&D, I am excited to continue contributing to the development of innovative medicines, now with a broader focus on global development in hematologic malignancies.
I am grateful to everyone who has supported and inspired me throughout my journey so far, and I look forward to this next chapter and to continuing to learn, collaborate, and make a meaningful difference together.”
Other articles about AstraZeneca on OncoDaily.